DexCom Inc (DXCM)
Pretax margin
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) | US$ in thousands | 709,000 | 710,400 | 390,800 | 173,900 | 225,000 |
Revenue | US$ in thousands | 4,033,000 | 3,622,300 | 2,909,800 | 2,448,500 | 1,926,700 |
Pretax margin | 17.58% | 19.61% | 13.43% | 7.10% | 11.68% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $709,000K ÷ $4,033,000K
= 17.58%
The pretax margin of DexCom Inc has shown fluctuations over the past five years. In December 31, 2020, the pretax margin stood at 11.68% and decreased to 7.10% by December 31, 2021. However, from December 31, 2022, there has been a steady increase in the pretax margin, reaching 13.43% in 2022, 19.61% in 2023, and 17.58% in 2024. This indicates improving profitability before taxes in recent years, with a notable surge in 2023. DexCom Inc's management may have implemented strategies to enhance operational efficiency and cost management, leading to a healthier pretax margin performance in the last two years.
Peer comparison
Dec 31, 2024